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Abstract
Skin cancer screening has undoubted potential to reduce cancer-speciﬁc morbidity and mortality. Total-body exams remain the
prevailing concept of skin cancer screening even if effectiveness and value of this method are controversial. Meanwhile, store and
forward teledermatology was shown to be a reliable instrument for several diagnostic purposes mostly in specialized dermatology
settings. The objective of this study was to evaluate most convenient mobile teledermatology interventions as instruments for skin
cancer screening in a representative population.
Prospective diagnostic study with visitors of a skin cancer screening campaign in Switzerland. Histopathology was used as
reference standard. Mobile teledermatology with or without dermoscopic images was assessed for performance as a screening test
(i.e., rule-in or rule-out the need for further testing). Outcomes were sensitivity, speciﬁcity, and predictive values.
Seven cases of skin cancer were present among 195 skin lesions. All skin cancers were ruled-in by teledermatology with or without
dermoscopic images (sensitivity and negative predictive value 100%). The addition of dermoscopic images to conventional images
resulted in higher speciﬁcity (85% vs. 77%), allowing reduction of unnecessary further testing in a larger proportion of skin lesions.
Store and forward mobile teledermatology could serve as an instrument for population-based skin cancer screening because of
favorable test performance.
Abbreviations: CI = Conﬁdence Interval, OR = Odds ratio.
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1. Introduction
Skin cancer is on the rise globally and especially so in
Switzerland.[1] Campaigns to raise awareness and foster preven-
tion and early detection of skin cancer are ongoing since over a
decade.[2,3] Owing to superﬁcial growth and natural course
running through preclinical stages, skin cancer is highly amenable
for screening interventions with potential economical and health-
beneﬁts.[4,5] The selection of the population to screen, the kind of
healthcare professionals to appoint, and the type of clinical
assessment to perform, however, are still to debate. Moreover,
the effectiveness of skin cancer screening in general still remains
to be determined.[6] So far, the prevailing concept of skin cancer
screening is the total-body exam executed by trained physicians.
This type of intervention, however, is very expensive and possibly
disproportional to introduce on a population-based scale. The
nationwide skin cancer screening program in Germany, for
instance, relied on total-body exams but surprisingly failed to
result in improvements of skin cancer mortality rates despite
promising results from a pilot project.[7,8] The role of total-body
exams might be the one of a case-ﬁnding procedure in an at-risk
population, rather than a population-based screening interven-
tion. In contrast, lesion directed examinations are more time-
efﬁcient and have similar detection rates, but still require time-
expensive face-to-face consultations and similar constraints as to
total-body examinations apply.[9] Teledermatological assess-
ments on the other hand, especially lesion directed store and
forward procedures can be performed in a most speedy manner.
In several former studies, the reliability of teledermatology based
management recommendations was shown to be comparable to
face-to-face consultations.[10–15] Moreover, recent technical
advancements led to mobile phone assisted dermoscopy even
enabling “mobile teledermoscopy,” combining high technical
standards of teledermatological image acquisition with mobile
phone convenience. Feasibility and reliability for cancer detection
with such mobile teledermoscopy has already been shown in high
prevalence settings.[16,17]
Given time-efﬁciency, reliability, and the widespread dissemi-
nationof powerful digital cameras integrated inmobile phones, the
remaining technical limitations tomobile teledermatology for skin
cancer screening are few and may lie in standardization of the
speciﬁc methods of image acquisition to achieve highest possible
reliability.[18] Once these issues are resolved, image acquisition
could be transferred to settings outside medical practices and
broader population based screening could be implemented.
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To assess a screening intervention in this context, test
performance measures (sensitivity, speciﬁcity, and predictive
values) in directing malignant lesions to further evaluation (and
treatment) and withholding these measures in non-malignant skin
lesions are needed to know. Also, the detection rate of malignant
skin lesions (i.e., number needed to screen) in a representative low-
prevalence setting is relevant to estimate the value of the screening
intervention. So far, however, only little research in mobile
teledermatology has been conducted in settings representative for
population based screening, and research concentrated on
specialized secondary or tertiary care settings. Furthermore, the
additional value of teledermoscopy on top of conventional
teledermatology for screening interventions is still unclear.
Therefore, the aim of this study was to estimate the diagnostic
performance (sensitivity, speciﬁcity, and predictive values) of
lesion-directed mobile teledermatology with or without dermo-
scopic imaging as a skin cancer screening intervention in a
population representing a low-prevalence setting.
2. Methods
2.1. Study design
We conducted a prospective diagnostic study with data collection
during a public skin cancer screening campaign at the
Department of Dermatology at the University Hospital of Zürich
in May 2013. Ethics committee of the Canton of Zürich
approved the study on May 8, 2013 (KEK-ZH-Nr. 2013–0119).
The study was conducted according to the tenants of the
declaration of Helsinki and to good clinical practice standards.
2.2. Screening campaign and participants
The “National skin cancer day” is a yearly conducted skin cancer
screening campaign in Switzerland and is carried out in
dermatology clinics and hospitals since 2006. Anyone interested
may visit a participating site without scheduled appointment to
present speciﬁc skin lesions to be checked for malignancy (total-
body exams are not performed). In order to reduce administrative
expenditures during the campaign, participants do not register at
the clinic but are guided through the screening anonymously
without any information being documented. For the purpose of
this study and to evaluate quality of the procedures during the
campaign, we prospectively documented skin lesions with digital
images and structured clinical information and followed out-
comes of biopsies.
At the reception, participants were given consecutive numbers
in order of their appearance in the clinic. Participants were then
allocated to 1 of 18 examination rooms. In 8 of the 18
examination rooms, personnel and camera equipment for study
participation was available and participants were approached for
study participation. The allocation to the 18 examination rooms
was performed consecutively in order of appearance at the
reception and according to availability in next possible
examination room. Thereby, we sought to prevent selection of
speciﬁc skin lesions for speciﬁc examination rooms. We included
skin lesions of participants that provided informed consent and
the documentation of the skin lesion with macroscopic and
microscopic digital images succeeded.
2.3. Clinical measures and skin cancers
The lesion-directed clinical examinations were performed by
residents of the Department of Dermatology with an on-call
backup by senior staff for assistance in uncertain cases. From
examinations, the following data were ﬁlled in a standardized
form: age, sex, personal or family history of skin cancer, skin type
according to Fitzpatrick, the estimated total number of moles
(>100 or <100), suspected diagnoses and management recom-
mendations for the skin lesion under question.
When skin cancer was suspected, participants were offered
appointments (immediately or within a few days) to remove the
skin lesions or to perform biopsy. The biopsy results were
available to us and served as the reference standard for skin
cancer being present or not. When skin cancer was ruled out
clinically, obviously no additional biopsy was performed and the
clinical decision served as reference standard.
2.4. Teledermatology method and measures
2.4.1. Image acquisition:.Medicine students who completed a 1-
hour training workshop in skin lesion photography acquired 3
images of every skin lesion utilizing the integrated 5-megapixel
camera of an iPod (Apple Inc.) touch ﬁfth generation. First, an
overview image that showed anatomical region of the lesion, second
a macroscopic image from approximately 10cm that showed the
surrounding skin including the dispersion of other skin lesions, third
a dermoscopic image was taken using the Handyscope (FotoFinder
SystemsGmbH, Bad Birnbach, Germany) (purpose-built attachable
dermoscope that converts an iPhone or iPod touch into a digital
dermoscope for mobile skin examinations, allowing polarized and
non-polarized images of up to 20 times magniﬁcation; the product
was not Food and Drug Administration labeled for the use under
discussion).[19] All acquired images were JPEGs with a resolution of
25921936 pixels.
2.4.2. Teledermatological assessment:. The images were
arranged by skin lesions and organized in 2 packages, the ﬁrst
package including macroscopic images only and the second
package including the additional teledermoscopic images. The
packages were stored on encrypted hard-drives and sequentially
forwarded to the teledermatologist (see acknowledgment) with a
1-month washout time interval between the ﬁrst and the second
package. The teledermatologist was a board certiﬁed dermatolo-
gist and very experienced in the teledermatological examination
of skin lesions including digital teledermoscopy. Along with the
images, the teledermatologist was given the information about
the patients’ age, sex, history of skin cancer, Fitzpatrick skin type,
and the estimated number of moles retrieved from the
questionnaire of the clinical examination. The teledermatologist
was aware of her task being skin cancer screening but was left
unaware of the aim of the study and blinded towards suspected
diagnoses and management recommendations already given by
the dermatologists at the screening campaign and towards biopsy
results. For every skin lesion, the teledermatologist ﬁrst decided
whether the provided images were adequate to allow assessment
for cancer screening at all. Secondly, in adequate cases,
management recommendations had to be given in 3 categories:
(a) no follow-up required, (b) clinical assessment required, (c)
direct excision or biopsy.
2.5. Statistical analysis
Quantitative variables are reported as medians and interquartile
ranges, categorical variables are reported as counts and
proportions. Management recommendations from teledermatol-
ogy were dichotomized as follows: “no follow-up required” was
categorized as negative outcome of the screening test and
“clinical assessment required” or “direct excision or biopsy”was
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categorized as positive test outcome. Skin lesions that had
histopathology-conﬁrmed skin cancers were categorized as
cancer-positive, all others as cancer-negative.
We calculated the number of patients to be screened to detect a
case of skin cancer, by dividing the total number of histology
conﬁrmed skin cancer by the number participants included in the
study. Furthermore, we calculated test sensitivity, speciﬁcity, and
predictive values in according to the test outcomes categorized
above with reference to cancer being present or not according to
the biopsy conﬁrmed results. Agreement between teledermatol-
ogy and gold standard are expressed by concordance rate as well
as Cohen’s Kappa (k). All analyses were performed in duplicate
for the 2 test methods with or without teledermoscopic images.
2.6. Outcomes
The primary outcomes of this study were the test performance
measures of teledermatology with and without teledermoscopy.
Further outcomes were the practicability of the techniques
measured by skin lesions the teledermatologist rated to be
suitable to perform cancer screening, moreover as an estimate of
potential value of the screening intervention we calculated the
number of skin lesions needed to be screened to detect 1 case of
skin cancer.
3. Results
3.1. Population
A total of 412 skin lesions (in 405 patients) were counted at the
screening campaign on May 13th, 2013 and 225 skin lesions
were seen in examination rooms equipped for study participa-
tion. In 13 (5.8%) of these informed consent was unavailable and
in 17 (7.6%) no digital images were acquired because of technical
problems, thus resulting in 195 (86.7%) of the eligible skin
lesions included in the study (Fig. 1).
Skin lesions in the study originated from a total of 188 patients,
population characteristics are given in Table 1. The clinically
suspected diagnoses and management recommendations for skin
lesions are summarized in Table 2. The prevalence of malignancy
in the sample was 3.6%.
3.2. Practicability of teledermatology as screening test
and number needed to screen
Conventional images alone were suitable to perform skin cancer
screening in 182 (93.3%) of the cases, in the image package
including teledermoscopic images 192 (98.5%) skin lesions were
suitable. To detect 1 case of skin cancer, we needed to screen 27
skin lesions in our sample.
3.3. Performance of teledermatology as screening tests
Test performance measures of conventional teledermatology
were 100% sensitivity, 76.6% speciﬁcity, 14.6% positive
predictive value, and 100% negative predictive value. Conven-
tional teledermatology was able to rule-out the need for any
further follow-up in 134 of 182 skin lesions (73.6%) without
missing any of the skin cancers in the sample. Overall
concordance of conventional teledermatology with reference
standard was 77.5% (k=0.20).
Additional teledermoscopy on top of conventional telederma-
tology performed with 100% sensitivity, 84.9% speciﬁcity,
20.0% positive predictive value, and 100% negative predictive
value. The rule-out of any further follow-up was possible in 157
of 192 (81.8%) skin lesions without missing any of the skin
cancers in the sample. Overall concordance of teledermatology
featuring teledermoscopy with reference standard was 85.4%
(k=0.29).
Detailed cross tabulation of test outcomes according to the
reference standard is given (supplemental information ﬁles 1 and
2, http://links.lww.com/MD/B591).
3.4. Additional exploratory analyses
In order to assess whether different levels of clinical presentations
were associated with different test-performance, we applied a
binomial logistic regression model with the dependent variable
being the agreement of the teledermatology with reference
standard. As independent variables, we added all clinical
variables from the clinical assessment.
For teledermatology without teledermoscopic images we found
no association of clinical presentations with test performance. In
teledermatology including teledermoscopy, however, the clinical
presentations of atypical mole and age were both associated with
lesser odds for agreement with reference standard: atypical mole
odds ratio for agreement (OR)=0.05 (95% conﬁdence interval
[CI]=0.001–0.28); age OR=0.96 (95% CI=0.92–0.99).
4. Discussion
In this study, mobile teledermatology detected all cases of skin
cancer in a low prevalence population and accurately ruled out
the necessity of further testing in 3 out of 4 cases. Mobile
teledermoscopy in addition to conventional images increased
speciﬁcity of the screening allowing correct rule-out in 4 out of 5
skin lesions. Mobile teledermoscopy also had higher practicabili-
ty featuring a substantially lower rate of images classiﬁed as
inadequate for screening compared with conventional mobile
teledermatology.
Findings from our study are in line with previous research
demonstrating very high cancer detection rates of mobile
teledermoscopy in high-prevalence settings.[16,17] In a very
similar setting as ours, a high management concordance between
face-to-face consultations and conventional teledermatology has
recently been found and cancer screening utilizing teledermatol-
ogy was suggested.[20] Here, we followed the diagnostic
chain beyond agreement with clinical management recommen-
dations (suffering from interrater variability) and linked the
results to a valid gold-standard represented by histopathology,
therefore allowing test performance measurements in a screening
population.
The speciﬁc methods in skin cancer screening are still to debate
and our results emphasize teledermatology’s potential contribu-
tion to this ﬁeld: ﬁrst, sensitivity and negative predictive value for
ruling in skin cancers (to either subsequent clinical assessment or
direct excision) was 100% clearly arguing for qualiﬁcation of the
technique as a screening intervention, because no case of skin
cancer was falsely ruled out. Furthermore, only minimal training
of photographers was needed to enable acquisition of images
suitable for the teledermatologist arguing for practicability of the
technique. We did not systematically assess the teledermatolo-
gist’s time expenditures to perform the assessments; however,
each set (consisting in almost 200 images) was ﬁnished within
“one afternoon” strongly arguing for time-efﬁciency of the
procedure considering that the image material was derived from
face-to-face exams performed by 8 physicians working an entire
Markun et al. Medicine (2017) 96:10 www.md-journal.com
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day each. Looking at the additional value of teledermoscopy on
top of conventional teledermatology, we found that more skin
lesions were suitable to be screened but more importantly,
speciﬁcity increased allowing more lesions to be ruled-out by the
screening with the exception of atypical moles. Thus, considering
that additional expenses in technical equipment and time to
perform 1 additional image are small, mobile teledermoscopy
might be a valuable enhancement in addition to conventional
mobile teledermatology because it can effectively decrease
unnecessary follow-up exams due to false-positive screening
outcomes.
Our results show how teledermatology could contribute to
skin cancer screening by image acquisition also outside medical
practice by minimally instructed personnel (possibly even
patients themselves) as piloted for other clinical questions in
dermatology.[21] Similar procedures are by now only proposed
and integrated in remote and medically under-supported areas
but such a service might also decrease skin cancer rates in other
healthcare settings when offered to the broad population.[22]
Even if total-body exams presumably have higher detection rate
in 1 speciﬁc individual, the population-wide detection rate may
be higher using a teledermoscopy service. This because of lower
Figure 1. Study ﬂow-chart and outcome counts.
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barriers and easier access to teledermatology than to total-body
exams and because of already very high acceptance among the
population.[23] Notably, such a screening would ultimately
depend on self-detection of skin lesions by individuals among the
population. The comparably high cancer rate we found in our
population speaks in favor of the population’s ability for self-
detection, furthermore this ability has speciﬁcally been found
before in a comparable screening setting.[24]
4.1. Strengths and limitations
The main strength and novelty of our study is the head-to-head
comparison of teledermatological skin cancer screening inter-
ventions in a representative population with a valid gold-
standard available. Limitations to this study are the following:
ﬁrst, only 1 teledermatologist was involved and since there is no
standardized training or generally accepted method of image
acquisition and image evaluation, reproducibility of our results is
uncertain. The low-level of efforts needed to implement image
acquisition combined with the positive results per se, however,
are encouraging for further pursuit of the concept. Secondly,
teledermatology may still have missed skin cancers because
histopathology was not available in every 195 skin lesion
assessed, however, these hypothetical skin cancers would have
also been missed by the face-to-face examinations. Therefore,
teledermatology was at least non-inferior to face-to-face
examinations that are themselves the commonly accepted
standard in skin cancer screening.
4.2. Recommendations for further research
For further research we suggest that teledermatology’s test
performance is investigated depending on reproducible standards
of image acquisition and image evaluation using skin lesions
originating from a population representative for skin cancer
screening. Especially, there might still be room left to improve
speciﬁcity of the screening without renouncing sensitivity that
appears already to be very high. Further steps then include
research in delivery and design of a population-based tele-
dermatology screening intervention (i.e., with image acquisition
outside medical practices) before a population wide reduction of
skin cancer burden can be attempted.
We conclude that store and forward mobile teledermatology is
inexpensive, practicable, and able to produce highly accurate
management recommendations in the speciﬁc role of skin cancer
screening. Population-based skin cancer prevention programs
could consider implementing mobile teledermatology services as
screening tests rather than directly offering total-body exams.
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